Genetic factors in hepatic drug oxidation.
D000818:Animals; D000983:Antipyrine / Q000378:metabolism; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000166:cytology / Q000201:enzymology / Q000378:metabolism*; D008214:Lymphocytes / Q000378:metabolism; D008297:Male; D008322:Mammals; D006899:Mixed Function Oxygenases / Q000378:metabolism; D008954:Models, Biological; D009661:Nortriptyline / Q000378:metabolism; D010084:Oxidation-Reduction; D004364:Pharmaceutical Preparations / Q000097:blood / Q000378:metabolism*; D010672:Phenytoin / Q000378:metabolism; D051381:Rats
D004364:Pharmaceutical Preparations; D010672:Phenytoin; D003577:Cytochrome P-450 Enzyme System; D009661:Nortriptyline; D006899:Mixed Function Oxygenases; D000983:Antipyrine